Medical Cannabis Market Size, Value, Trends, Industry Overview, Outlook and Business Opportunity 2022-2027

The medical cannabis market is projected to reach $52.1 billion by 2027 and to show a CAGR of 10.4% over the period 2022-2027.

Sheridan, Wy, USA, November 14, 2022 / to Imarc Groupโ€™s Latest Report, Titleded โ€œ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐‚๐š๐ง๐ง๐š๐›๐ข๐ฌ: ๐†๐ฅ๐จ๐›๐š๐ฅ ๐“๐ซ๐ž๐ง๐๐ฌ, ๐’๐ข๐ณ๐ž, ๐’๐ข๐ณ๐ž, ๐†๐ซ๐จ๐ฐ๐ญ๐ก, ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐š๐ง๐ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•โ€, the global The medical cannabis market size reached $26.1 billion in 2021. Looking ahead, IMARC Group expects the market to reach $52.1 billion by 2027, at a CAGR of 10.4% over 2022-2027.

Medical cannabis, or hash and dope, represents a group of three psychoactive plants known as Cannabis Sativa, Indica, and Ruderalis, which are grown in tropical and temperate regions. It is usually made from cannabis sativa flowers and leaves that are extensively dried and cured to enhance flavor and produce a cleaner and smoother smoke. Medicinal cannabis possesses calming, therapeutic and sedative properties that reduce depression and treat glaucoma and chronic pain. Apart from that, regular use of medical cannabis helps in treating post-traumatic stress disorder and acquired immune deficiency syndrome (AIDS). Consequently, it is used in capsules, lozenges, skin patches, and edible forms for post-prescription treatment purposes.

๐†๐ž๐ญ ๐…๐ซ๐ž๐ž ๐…๐ซ๐ž๐ž ๐‚๐จ๐ฉ๐ฒ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐‚๐š๐ง๐ง๐š๐›๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Growing consumer awareness of product availability and its multiple therapeutic benefits, as well as rising demand for cannabis-based therapies are primarily driving the market growth. Compared to traditional alternative treatments, medicinal hash is safer and has fewer side effects; As such, it is often used in conjunction with therapies to enhance its effectiveness and minimize unwanted side effects. Furthermore, extensive inhalation of medicinal cannabis to reduce epileptic seizures and several oncological health complications favors market growth as they contain active ingredients such as cannabidiol (CBD) and tetrahydrocannabinol (THC). In addition, increasing disposable income, rising product demand in the nutraceuticals industry and ongoing initiatives by governments of different regions to promote legalization of cannabis for medical purposes are positively stimulating the market growth.

๐‚๐ก๐ž๐œ๐ค๐จ๐ฎ๐ญ ๐๐จ๐ฐ:

Competitive landscape with key players:

The competitive landscape of the Medical Cannabis market has been studied in the report that provides the detailed profiles of the major market players.

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž๐ฌ๐ž ๐ค๐ž๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐ข๐ง๐œ๐ฅ๐ฎ๐:

โ€ข Canopy Growth Corporation
โ€ข GW Pharmaceuticals, plc
โ€ข Aurora Cannabis, Inc.
โ€ข Aphria, Inc.
โ€ข MedReleaf Corporation
โ€ข Insys Therapeutics, Inc.
โ€ข CanniMed Therapeutics, Inc.
โ€ข Cara Therapeutics, Inc.
โ€ข United Cannabis Corporation

Key Market Segmentation:

The report has segmented the medicinal cannabis market based on species, derivatives, application, end-use, route of administration, and region.

Breakdown by species:

โ€ข Indica
โ€ข Sativa
โ€ข Hybrid

Breakdown by derivatives:

โ€ข Cannabidiol (CBD)
โ€ข Tetrahydrocannabinol (THC)
โ€ข Other

Separation by application:

โ€ข Cancer
โ€ข Arthritis
โ€ข migraines
โ€ข Epilepsy
โ€ข Other

Breakdown by End Use:

โ€ข Pharmaceutical industry
โ€ข Research and development centers
โ€ข Other

Separation by route of administration:

โ€ข Oral solutions and capsules
โ€ข Evaporator
โ€ข Subjects
โ€ข Other

Breakdown by region:

โ€ข North America (United States, Canada)
โ€ข Europe (Germany, France, UK, Italy, Spain, Russia, others)
โ€ข Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, others)
โ€ข Latin America (Brazil, Mexico, others)
โ€ข Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, others)

๐€๐ฌ๐ค ๐Ÿ๐จ๐ซ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐š๐ง๐ ๐ฐ๐ข๐ญ๐ก ๐ฐ๐ข๐ญ๐ก ๐“๐Ž๐‚ ๐“๐Ž๐‚ ๐‹๐ข๐ฌ๐ญ ๐‹๐ข๐ฌ๐ญ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ:

Key highlights of the report:

โ€ข Market performance (2016-2021)
โ€ข Market Outlook (2022-2027)
โ€ข Market Trends
โ€ข Market drivers and success factors
โ€ข Effects of COVID-19
โ€ข Value chain analysis
โ€ข Comprehensive mapping of the competitive landscape

If you require specific information that is not currently in the scope of the report, we will provide it as part of the customization.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Medical Cannabis Market in Thailand:

RCM Healthcare Outsourcing Market:

about us

IMARC Group is a leading market research company providing management strategies and market research worldwide. We partner with clients across sectors and geographies to identify their most valuable opportunities, address their most critical challenges, and transform their businesses.

IMARCโ€™s information products cover key market, scientific, economic and technological developments for executives in pharmaceutical, industrial and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food & beverage, travel & tourism, nanotechnology and advanced processing methods are at the forefront of the companyโ€™s expertise.

Our offer includes comprehensive market information in the form of research reports, production cost reports, feasibility studies and consulting services. Our team, which includes experienced researchers and analysts across multiple industries, is dedicated to delivering high-quality data and insights to our clientele, ranging from small and medium-sized businesses to Fortune 1000 companies.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here

Comments are closed.